Iridex Corp
IRIX- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001006045
In the last 90 days, Iridex Corp insiders filed 4 open-market purchases and 0 sales; 29 institutions reported holding it in 13F filings for Q2 2026, worth $2.47M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Iridex Corp changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 24 | 20 | −4 |
| Shares | 3.15M | 2.69M | −456.9K (−14.5%) |
| Value | $3.19M | $2.37M | −$819.9K (−25.7%) |
New holders (3)
Institutions that held Iridex Corp at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Thompson Davis & Co., Inc. | 56,726 | $50.0K | 0.03% |
| Susquehanna International Group, LLP | 38,636 | $34.1K | 0.00% |
| Raymond James Financial Inc | 700 | $617 | 0.00% |
Sold out (7)
Institutions that held Iridex Corp at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| ARS Investment Partners, LLC | 110,060 | $184.9K |
| Concurrent Investment Advisors, LLC | 21,944 | $21.7K |
| Dimensional Fund Advisors LP | 14,549 | $14.4K |
| UBS Group AG | 1,502 | $1.49K |
| West Paces Advisors Inc. | 135 | $134 |
| JPMorgan Chase & Co | 27 | $27 |
| Simplex Trading, LLC | 125 | $0 |